Mostafa Mousavizadeh

ORCID: 0000-0002-1914-697X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aortic Disease and Treatment Approaches
  • Cardiac Valve Diseases and Treatments
  • Aortic aneurysm repair treatments
  • COVID-19 and healthcare impacts
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipose Tissue and Metabolism
  • Blood Pressure and Hypertension Studies
  • Congenital Heart Disease Studies
  • COVID-19 Clinical Research Studies
  • Cardiac Structural Anomalies and Repair
  • Natural Antidiabetic Agents Studies
  • Cardiac and Coronary Surgery Techniques
  • Infectious Aortic and Vascular Conditions
  • Liver Disease Diagnosis and Treatment
  • Bone Metabolism and Diseases
  • Cardiovascular Function and Risk Factors
  • Metabolism, Diabetes, and Cancer
  • COVID-19 and Mental Health
  • Biochemical Acid Research Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Obesity, Physical Activity, Diet
  • Cancer, Lipids, and Metabolism
  • Lipoproteins and Cardiovascular Health
  • Cell Adhesion Molecules Research

Shahid Beheshti University of Medical Sciences
2020-2024

Shaheed Rajaei Cardiovascular Medical and Research Center
2020-2023

Iran University of Medical Sciences
2020-2022

Heidelberg University
2021-2022

Velindre NHS Trust
2022

Heidelberg University
2021

Tehran University of Medical Sciences
2011-2018

Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic prophylaxis.To evaluate effects intermediate-dose vs standard-dose prophylactic anticoagulation among COVID-19 admitted intensive care unit (ICU).Multicenter randomized trial a 2 × factorial design performed 10 academic centers Iran comparing (first hypothesis) and statin therapy matching placebo (second hypothesis; not this article) adult ICU Patients...

10.1001/jama.2021.4152 article EN JAMA 2021-03-18

Abstract Background Addition of spironolactone (SPR) to angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) might provide antiproteinuric effects beyond what is gained by either medication alone. This study was designed assess the long-term efficacy SPR/ARB combination in comparison with standard ACE/ARB regimen diabetic nephropathy. Methods In an open-label, parallel-group, single-center, randomized clinical trial (NCT01667614), 136 patients diabetes...

10.1093/ndt/gft281 article EN Nephrology Dialysis Transplantation 2013-09-05

The aim of the present study was to determine prevalence metabolic syndrome and its individual components among Iranian adult population in 2011 investigate changes between 2007 2011.Data from two rounds Surveillance Risk Factors Non-communicable Diseases national surveys conducted were pooled. Metabolic defined according International Diabetes Federation criteria.In 2007, adults aged 25-64 years 35.95 (95% confidence interval [CI] 34.27-37.63), which decreased 32.96 CI 30.73-35.18) (P =...

10.1111/1753-0407.12438 article EN Journal of Diabetes 2016-06-05

Background Previous studies evaluating the relationship between serum vaspin concentrations and metabolic syndrome (MetS) have yielded contrasting results. Additionally, contribution of general abdominal obesity, chronic inflammation, insulin resistance to this remains unknown. Methods In a cross-sectional setting, we investigated association MetS in 145 subjects ranging from normoglycemia type 2 diabetes. Vaspin were measured using enzyme-linked immunosorbent assay. Results Women had 29%...

10.4093/dmj.2014.38.2.143 article EN cc-by-nc Diabetes & Metabolism Journal 2014-01-01

Coronary heart disease (CHD) is one of the most common causes mortality worldwide. The national prevalence remains unclear in developing countries.This study sought to estimate self-reported CHD and chronic stable angina pectoris general adult population Iran using data from fourth round Surveillance Risk Factors Non-Communicable Diseases (SuRFNCD-2011) survey.The analysis comprised 11,867 civilian, nonhospitalized noninstitutionalized residents ages 6 70 years age. calculated were...

10.1016/j.gheart.2018.01.001 article EN cc-by Global Heart 2018-02-10

Chemerin, a novel member of the family adipocytokines, has been shown to be associated with insulin resistance, as well micro- and macrovascular complications diabetes. We investigated effects pioglitazone metformin, two commonly prescribed antidiabetic agents, on reduction serum chemerin concentrations. In an open-labeled randomized clinical trial, 81 patients newly diagnosed type 2 diabetes who were not taking medications recruited. Patients randomly assigned either 30 mg daily or...

10.1111/jdi.12157 article EN cc-by-nc Journal of Diabetes Investigation 2013-10-22

<b>Aim:</b> The etiologic role of inflammatory pathways in the development diabetic complications, especially cardiovascular events, has been established. anti-inflammatory metformin and pioglitazone described; however, no study to date compared efficacy these common oral agents this regard. In study, authors aimed compare properties metformin, with respect their effect on serum concentrations highly sensitive C-reactive protein (hsCRP), osteoprotegerin (OPG), intercellular adhesion...

10.1055/s-0034-1396864 article EN Experimental and Clinical Endocrinology & Diabetes 2015-01-21
Coming Soon ...